How did RJF's Q2 2025 EPS forecast compare to past trends?

**Raymond James Financial's (RJF) Q2 2025 EPS forecast is not currently available**, and thus cannot be directly compared to past trends based on specific EPS figures. However, we can analyze the company's historical EPS performance and trends using the available data. 1. **Historical EPS Performance**: - In Q3 2024, RJF's non-GAAP EPS was $2.39, which beat the consensus estimate by $0.06. This indicates a strong earnings performance for the period. - In Q1 2023, the non-GAAP EPS was $2.29, which beat the consensus by $0.01. This suggests a consistent performance with a slight edge over expectations. - In Q1 2024, the non-GAAP EPS was $2.40, which beat the consensus by $0.14. This confirms a trend of exceeding expectations in EPS. - In Q2 2023, the non-GAAP EPS was $2.03, which missed the consensus by $0.21. This was a notable miss, indicating a low point in the earnings trend. 2. **Trends and Variations**: - The EPS has shown a general upward trend with some fluctuations. The highest beat was $0.14 in Q1 2024, while the most significant miss was $0.21 in Q2 2023. - The fact that RJF has consistently exceeded expectations in most quarters, with the exception of a notable miss in Q2 2023, suggests a strong and stable financial performance. 3. **Comparison to CAGR**: - The 5-year EPS CAGR is not currently available, which makes a direct comparison to past trends impossible. However, the consistency of beating or meeting expectations suggests a positive growth trajectory. 4. **Institutional Activity**: - Institutional investors have shown interest in RJF, with recent purchases by Raymond James Financial Inc. in various companies, including Equinor ASA, Costamare Inc., Portillo's Inc., Maui Land & Pineapple Company, Inc., and GDS Holdings Limited. This could be indicative of confidence in RJF's performance and potential for growth. In conclusion, while the specific EPS for Q2 2025 is not available, the historical performance of RJF shows a generally increasing trend with strong earnings beats in recent quarters. The absence of a 5-year CAGR for EPS limits a direct comparison, but the consistent performance and recent institutional investments suggest optimism for the company's future financial health.